ICER Requests Public Input To Identify Drugs For Price Hike Report

By Gabrielle Wanneh / April 16, 2024 at 5:07 PM
The Institute for Clinical and Economic Review (ICER) has released the official procedures for conducting its sixth assessment of major drugs that experienced substantial price increases without adequate evidence to justify the increases. The drug pricing watchdog will identify 10 drugs with net price hikes that have generated the largest increase in drug spending at the federal level and is seeking public input for an additional three drugs that have experienced similar price increases over the same timeframe but won’t...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.